Stay updated on UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial
Sign up to get notified when there's something new on the UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial page.

Latest updates to the UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial page
- CheckyesterdayChange DetectedThe update is limited to a minor revision notice: Revision: v3.3.4 is now shown and the previous Revision: v3.3.3 is removed; no study data, eligibility criteria, or page functionality are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedFooter updates include a new Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link, with the previous Revision: v3.3.2 no longer shown. These changes do not affect core study information or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.3.2 added; the page shows the updated revision tag.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedThe top funding/operating-status notice was removed. The core study details and navigation remain unchanged.SummaryDifference0.3%

- Check73 days agoChange DetectedThe screenshots show the same Study Details page with only minor layout adjustments and a slight difference in the last update timestamp; no substantive changes to the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial page.